Yoshihiro Doi

A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of Primary Aldosteronism

Tsutomu Abe, Mitsuhide Naruse, William F. Young et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 72 citations · Full text

Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas

Toshio Sasajima, Takahiro Ono, Naoya Shimada et al. · Nuclear Medicine and Biology · 2013 · 36 citations

Positron Emission Tomography, Neuro-oncology, Trans-1-amino-3-18f-fluorocyclobutanecarboxylic Acid +13

PET Tracer ¹⁸F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models

Shuntaro Oka, Masaru Kanagawa, Yoshihiro Doi et al. · Theranostics · 2017 · 20 citations · Full text

Comparison of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid (anti-[18F]FACBC) accumulation in lymph node prostate cancer metastasis and lymphadenitis in rats

Masaru Kanagawa, Yoshihiro Doi, Shuntaro Oka et al. · Nuclear Medicine and Biology · 2014 · 17 citations

Medicine, Pharmacology, Pathology +4

Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma

Takahiro Ono, Toshio Sasajima, Yoshihiro Doi et al. · Nuclear Medicine and Biology · 2015 · 14 citations

Neuro-oncology, Oncology, Oncologic Imaging +10